Cayir Yasemin, Ozdemir Gokhan, Celik Mine, Aksoy Hulya, Akturk Zekeriya, Laloglu Esra, Akcay Fatih
Department of Family Medicine, Ataturk University Faculty of Medicine, Erzurum, Turkey Research and Practice Center for Acupuncture and Complementary Therapy Modalities, Erzurum, Turkey.
Department of Neurology, Ataturk University Faculty of Medicine, Erzurum, Turkey.
Acupunct Med. 2014 Oct;32(5):376-80. doi: 10.1136/acupmed-2014-010612. Epub 2014 Aug 27.
To evaluate the effect of acupuncture on the serum matrix metalloproteinase-2 (MMP-2) level and activity in patients with migraine.
After baseline testing, eligible patients with migraine according to the criteria of the International Headache Society who volunteered to join the study were included (n=27). The patients received 10 sessions of acupuncture treatment. The points selected were bilateral ST8, ST44, LI4, LI11, LIV3, SP6, GB1, GB14, GB20, GV14, GV20, Yintang, Taiyang and ear Shenmen. Pain was measured using a visual analogue scale (VAS). Short form-36 (SF-36) was used to determine their quality of life. Blood samples were taken before treatment and after the first and last sessions of acupuncture for measurement of MMP-2 concentration and activity.
The mean VAS was 85.5±16.6 before acupuncture and was significantly decreased to 39.8±20.6 after 10 sessions of acupuncture (p<0.0001). There was a significant increase in all SF-36 scores after acupuncture compared with values before treatment (p<0.0001). No significant differences were found in MMP-2 concentrations before treatment and after the first and last sessions (p>0.05). However, there were significant changes in MMP-2 activity (p<0.0001).
The results of this study showed a clinically relevant decrease in MMP-2 activity in patients with migraine treated with acupuncture. The mechanism underlying the effect of acupuncture in alleviating pain may be associated with a decrease in MMP-2 activity.
评估针刺对偏头痛患者血清基质金属蛋白酶-2(MMP-2)水平及活性的影响。
在进行基线测试后,纳入符合国际头痛协会标准且自愿参加本研究的偏头痛患者(n = 27)。患者接受10次针刺治疗。选取的穴位为双侧ST8、ST44、LI4、LI11、LIV3、SP6、GB1、GB14、GB20、GV14、GV20、印堂、太阳穴及耳神门。采用视觉模拟评分法(VAS)测量疼痛程度。使用简明健康状况调查量表(SF-36)评估其生活质量。在治疗前、针刺首次及末次治疗后采集血样,测定MMP-2浓度及活性。
针刺前VAS平均分为85.5±16.6,针刺10次后显著降至39.8±20.6(p<0.0001)。与治疗前相比,针刺后所有SF-36评分均显著升高(p<0.0001)。治疗前与针刺首次及末次治疗后MMP-2浓度无显著差异(p>0.05)。然而,MMP-2活性有显著变化(p<0.0001)。
本研究结果表明,针刺治疗的偏头痛患者MMP-2活性在临床上有显著降低。针刺缓解疼痛的作用机制可能与MMP-2活性降低有关。